Cargando…
The Worm-Specific Immune Response in Multiple Sclerosis Patients Receiving Controlled Trichuris suis Ova Immunotherapy
Considering their potent immunomodulatory properties, therapeutic applications of Trichuris suis ova (TSO) are studied as potential alternative treatment of autoimmune disorders like multiple sclerosis (MS), rheumatoid arthritis (RA), or inflammatory bowel disease (IBD). Clinical phase 1 and 2 studi...
Autores principales: | Yordanova, Ivet A., Ebner, Friederike, Schulz, Axel Ronald, Steinfelder, Svenja, Rosche, Berit, Bolze, Anna, Paul, Friedemann, Mei, Henrik E., Hartmann, Susanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912101/ https://www.ncbi.nlm.nih.gov/pubmed/33572978 http://dx.doi.org/10.3390/life11020101 |
Ejemplares similares
-
Trichuris suis ova in relapsing-remitting multiple sclerosis and clinically isolated syndrome (TRIOMS): study protocol for a randomized controlled trial
por: Rosche, Berit, et al.
Publicado: (2013) -
Serum levels of brain-derived neurotrophic factor (BNDF) in multiple sclerosis patients with Trichuris suis ova therapy
por: Rosche, Berit, et al.
Publicado: (2013) -
Trichuris suis ova therapy in inflammatory bowel disease: A meta-analysis
por: Huang, Xing, et al.
Publicado: (2018) -
Influence of NOD2 Variants on Trichuris suis ova Treatment Outcome in Crohn’s Disease
por: Jaeger, Simon U., et al.
Publicado: (2018) -
Pathway of oxfendazole from the host into the worm: Trichuris suis in pigs
por: Hansen, Tina V.A., et al.
Publicado: (2017)